Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.5860
-0.0190 (-3.14%)
At close: Feb 27, 2026, 4:00 PM EST
0.6050
+0.0190 (3.24%)
After-hours: Feb 27, 2026, 7:55 PM EST
Vistagen Therapeutics Market Cap
Vistagen Therapeutics has a market cap or net worth of $23.22 million as of February 27, 2026. Its market cap has decreased by -69.57% in one year.
Market Cap
23.22M
Enterprise Value
-37.13M
1-Year Change
-69.57%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $23.22M, an increase of 149.65%. That is a compound annual growth rate of 9.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 23.20M | -11.11% |
| Dec 31, 2025 | 26.10M | -68.21% |
| Dec 31, 2024 | 82.10M | -40.89% |
| Dec 29, 2023 | 138.90M | 552.11% |
| Dec 30, 2022 | 21.30M | -94.53% |
| Dec 31, 2021 | 389.40M | 171.17% |
| Dec 31, 2020 | 143.60M | 381.88% |
| Dec 31, 2019 | 29.80M | -36.05% |
| Dec 31, 2018 | 46.60M | 258.46% |
| Dec 29, 2017 | 13.00M | -58.47% |
| Dec 30, 2016 | 31.30M | 236.56% |
| May 11, 2016 | 9.30M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences | 24.82M |
| Marker Therapeutics | 24.68M |
| Daré Bioscience | 24.29M |
| Skye Bioscience | 23.88M |
| Exicure | 23.84M |
| Barinthus Biotherapeutics | 23.80M |
| Hyperion DeFi | 23.68M |
| Genenta Science | 23.21M |